3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Lung Neoplasms
4
Clear-cell metastatic renal cell carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
asciminib
15
Cyclophosphamide
12
fludarabine phosphate
10
Mycophenolic Acid
9
fludarabine
8
nilotinib
7
Whole-Body Irradiation
7
Imatinib Mesylate
6
Dasatinib
6
Tacrolimus
5
Sirolimus
5
Cyclosporine
5
venetoclax
4
bosutinib
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
ponatinib
3
Thiotepa
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
Busulfan
3
thymoglobulin
2
ruxolitinib
2
Specimen Handling
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Blood Component Removal
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.